Being a “bad” patient

An expert advises a few things to keep in mind when patients with cancer are navigating these platforms.

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.

A study showed that patients with prostate cancer should consider the long-term side effects of treatments before deciding on the appropriate options.

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.

Younger patients with breast cancer and the BRCA gene showed improved survival after undergoing risk-reducing mastectomy and/or risk-reducing salpingo-oophorectomy.

I’m very grateful for my SLL medication, but I never thought a side effect of the medication would affect my wardrobe for the rest of my life.